Adiposopathy, “Sick Fat,” Ockham’s Razor, and Resolution of the Obesity Paradox

被引:0
作者
Harold Bays
机构
[1] Louisville Metabolic and Atherosclerosis Research Center,
来源
Current Atherosclerosis Reports | 2014年 / 16卷
关键词
Adiposopathy; Adiposity; Cholesterol; Diabetes mellitus; Lipids; Metabolic syndrome; Obesity; Obesity paradox; Ockham’s razor; Sick fat;
D O I
暂无
中图分类号
学科分类号
摘要
Among lean populations, cardiovascular disease (CVD) is rare. Among those with increased adiposity, CVD is the commonest cause of worldwide death. The “obesity paradox” describes seemingly contrary relationships between body fat and health/ill-health. Multiple obesity paradoxes exist, and include the anatomic obesity paradox, physiologic obesity paradox, demographic obesity paradox, therapeutic obesity paradox, cardiovascular event/procedure obesity paradox, and obesity treatment paradox. Adiposopathy (“sick fat”) is defined as adipocyte/adipose tissue dysfunction caused by positive caloric balance and sedentary lifestyle in genetically and environmentally susceptible individuals. Adiposopathy contributes to the commonest metabolic disorders encountered in clinical practice (high glucose levels, high blood pressure, dyslipidemia, etc.), all major CVD risk factors. Ockham's razor is a principle of parsimony which postulates that among competing theories, the hypothesis with the fewest assumptions is the one best selected. Ockham’s razor supports adiposopathy as the primary cause of most cases of adiposity-related metabolic diseases, which in turn helps resolve the obesity paradox.
引用
收藏
相关论文
共 290 条
  • [1] Walker AR(1997)Coronary heart disease: outlook for Africa J R Soc Med 90 23-7
  • [2] Sareli P(2001)Are health and ill-health lessons from hunter-gatherers currently relevant? Am J Clin Nutr 73 353-6
  • [3] Walker AR(2012)Hunter-gatherer energetics and human obesity PLoS One 7 e40503-8
  • [4] Pontzer H(1991)Cardiovascular disease risk factors in Australian aborigines Clin Exp Pharmacol Physiol 18 85-6
  • [5] Raichlen DA(2004)Optimal low-density lipoprotein is 50 to 70 mg/dl: lower is better and physiologically normal J Am Coll Cardiol 43 2142-37
  • [6] Wood BM(2009)“Sick fat,” metabolic disease, and atherosclerosis Am J Med 122 S26-5
  • [7] Mabulla AZ(2013)Letter to the Editor. Re: The science of obesity: what do we really know about what makes us fat? An essay by Gary Taubes Br Med J 346 f1050-23
  • [8] Racette SB(2003)Historical perspective: visceral obesity and related comorbidity in Joannes Baptista Morgagni’s ‘De sedibus et causis morborum per anatomen indagata’ Int J Obes Relat Metab Disord 27 534-73
  • [9] Marlowe FW(2007)Metabolic syndrome - what we know and what we don’t know J Am Soc Nephrol 18 1619-59
  • [10] O'Dea K(1947)La differenciation sexuelle, facteur determinant des formes de l’obesite Presse Med 55 339-5